A higher white blood cell (WBC) count has been shown to be a risk factor for myocardial infarction and stroke in middle-aged populations. This study evaluated the relation between baseline WBC count and other risk factors, as well as subclinical and prevalent disease, in the Cardiovascular Health Study, an epidemiologic study of coronary heart disease and stroke in 5,201 persons aged 65 years or older. Baseline data were collected over a 12-month period in [1989][1990]. WBC counts were statistically significantly higher in people with prevalent and subclinical atherosclerotic cardiovascular disease than in those who were free of disease. WBC counts correlated (p < 0.01) positively with coagulation factors, measures of glucose metabolism, creatinine, smoking, and triglycerides. In contrast, WBC counts correlated negatively with high density lipoprotein cholesterol, forced expiratory volume, forced vital capacity, and height. The correlations between WBC counts and nsk factors were similar in both the entire cohort and the subgroup of persons who had never smoked. The authors conclude that WBC counts in the elderly are associated with prevalent and subclinical atherosclerotic cardiovascular disease, as well as its risk factors. Am J Epidemiol 1996;143:1107-15.
A higher white blood cell (WBC) count has been demonstrated to be a risk factor for myocardial infarction (1-7) and stroke (8) in middle-aged populations. Higher WBC counts have also been associated with recognized risk factors for the development of atherosclerotic cardiovascular disease (ACD) in middle-aged (9, 10) and younger (11) populations. Cigarette smoking is a major confounding variable in these studies, because of the well-documented association of smoking with ACD and the increase in WBC count observed with smoking (12) (13) (14) . However, recent studies have documented the WBC count as an independent risk factor for ACD when data are controlled for smoking status (2, 4, 5, 15) .
The importance of the WBC count as a risk factor for the development of ACD in the elderly has not been explored. A variety of conventional risk factors in the elderly have shown patterns which differ from those seen in middle-aged populations, with a weakening of some risk factors (16) (17) (18) and even a seemingly protective effect of others (19, 20) . Thus, the surviving elderly population may differ in fundamental ways from the extensively investigated middleaged group.
The Cardiovascular Health Study was designed to identify risk factors for coronary heart disease, peripheral vascular disease, and stroke in individuals aged 65 years or more (21) . The purpose of the current investigation was threefold: 1) to report normative data for WBC count in the elderly; 2) to evaluate the association of WBC count with ACD risk factors, controlling for the effect of smoking; and 3) to explore the relations of WBC count with prevalent and subclinical ACD in the elderly.
MATERIALS AND METHODS

Design of the Cardiovascular Health Study
The design and methods used in the Cardiovascular Health Study have been previously described (21) and will be briefly reviewed here. During a 12-month period in [1989] [1990] 5 ,201 individuals entered the study from each of four field centers (Forsyth County, North Carolina; Sacramento County, California; Washington County, Maryland; and Pittsburgh, Pennsylvania). A home interview and clinic examination were conducted as part of the baseline examination. Informed consent was obtained and a standard questionnaire was completed which characterized the participant's social, medical, and dietary history.
The clinic examination included measurement of sitting blood pressure (using a random-zero sphygmomanometer; Hawksley and Sons, Ltd., Sussex, England), height, and weight. The MAC PC-DT electrocardiograph (Marquette Electronics, Inc., Milwaukee, Wisconsin) was used to obtain 12-lead resting electrocardiograms on all study entrants. The carotid arteries were examined by duplex ultrasonography with a Toshiba SSA-270A ultrasonograph equipped with a 5.0-MHz transducer (Toshiba America Medical Systems, Tustin, California). A Toshiba SSH-160A instrument with 2.5-MHz and 3.75-MHz transducers was used to perform echocardiography. Ultrasonographic, echocardiographic, and pulmonary function test methods and quality control have been described elsewhere (21) .
Blood measurements
Phlebotomy quality assurance, blood collection, and processing methods have been previously described (21) . A fasting blood sample was obtained shortly after the beginning of the participant's clinic visit, and another sample was collected 2 hours after a 75-g oral glucose load. Serum was collected for general chemical analysis (creatinine, albumin, glucose, and insulin). Plasma was collected into ethylenediamine tetraacetate and analyzed for plasma lipids (total cholesterol, high density lipoprotein cholesterol, and triglycerides). Plasma was collected into sodium citrate for measurement of coagulation factors (fibrinogen, factor VII, and factor VHT). A Kodak Ektachem 700 analyzer (Eastman Kodak, Rochester, New York) was used for general chemical analyses. Serum insulin was measured by solid-phase radioimmunoassay (Diagnostic Products, Los Angeles, California). Fasting lipid levels were determined using an Olympus Demand instrument (Olympus Corporation, Lake Success, New York) standardized by means of the Centers for Disease Control Lipid Standardization Program. The Friedewald formula was used to estimate low density lipoprotein cholesterol (22) . Coagulation factors were assayed as previously described (21) . Hematocrit, WBC counts, and platelet counts were determined at each of the four clinical centers with the following instruments: the University of Pittsburgh and the University of California at Davis used the Coulter Stack S cell counter (Coulter, Inc., Hialeah, Florida), and Wake Forest University and the Johns Hopkins University used the Sysmex NE8000 counter (Toa Electronics, Inc., Chicago, Illinois). All four laboratories participate in the College of American Pathologists' external quality control program for their automated cell counters.
Definitions
The following definitions of prevalent disease were used for these analyses: a medical history of myocardial infarction, angina, congestive heart failure, intermittent claudication, rheumatic heart or heart valve problems, atrial fibrillation, silent myocardial infarction, blood clots in the legs or lungs, stroke, or transient ischemic attack; a history of coronary bypass or other heart surgery, carotid endarterectomy, leg bypass, aortic aneurysm, pacemaker implant, or angioplasty of the heart or extremities; a positive response on the Rose questionnaire for angina or claudication; or use of digitalis, nitroglycerin, or Class 1A antiarrhythmic agents. There were 2,453 participants who had prevalent disease by one of these definitions.
A participant was considered to have subclinical disease if he/she had any of the following: an ankle:arm blood pressure ratio less than or equal to 0.9; major electrocardiographic abnormalities; a qualitatively abnormal left ventricular ejection fraction or abnormal left ventricular segmental wall motion by echocardiography (23); or maximum carotid stenosis of ^25 percent or an average carotid artery common far-wall thickness of ^1.2 by ultrasound (24) . Major electrocardiographic abnormalities included ventricular conduction defects, major Q-wave abnormalities, isolated ST-T segment abnormalities, left ventricular hypertrophy, atrial fibrillation, or first-degree atrioventricular block. There were 3,647 participants who had either prevalent disease or subclinical disease by one of these definitions.
Hypertension was defined as a seated systolic blood pressure greater than 160 mmHg, a seated diastolic blood pressure greater than 95 mmHg, or reported high blood pressure and use of hypertensive medication. Smoking was defined as current smoking, ever smoking, or passive smoking as previously described (21) . For ever smoking, no restrictions were placed on elapsed time since cessation of smoking. A positive family history of coronary heart disease was defined as a report of a sibling who died of myocardial infarction before reaching the age of 56.
Of the 5,201 Cardiovascular Health Study participants, 5,157 had their blood drawn for hematologic measurements. Eight implausible WBC counts rang-ing from 23.3 to 59.5 (number of cells X 10 9 /liter) were excluded. Thus, the data analyses were based on 5,149 (2,221 men and 2,928 women) WBC values.
Statistical analyses
Statistical differences among groups were determined using analysis of variance. In cases where there are only two groups, analysis of variance is equivalent to the two-sample t test. A linear trend among age groups was tested with the analysis-of-variance model. To meet the assumption of equal variances between groups (homoscedasticity), the square roots of the WBC counts were used. Pearson correlation coefficients were used to assess linear associations between the hematologic variables and other study measurements, which included the square root of WBC count, log triglycerides, and log fasting and 2-hour glucose and insulin values. The nonparametric Spearman's correlation coefficient was used for the results shown in table 5. Sex-specific multiple regression analysis was used to determine the linear relation between WBC count (square root) and the variables found in bivariate analyses to be significantly related (p < 0.05, two-sided) to WBC count.
In addition to data analyses on all participants, three subgroups were defined (see above) and used in analyses conducted to determine whether relations between the blood variables and other study variables depended on disease status. The three groups considered were the group with prevalent disease, the group with subclinical disease, and the group that was free of both prevalent and subclinical disease.
RESULTS
Distribution of WBC counts in the elderly, by sex and age
The distribution of WBC counts by sex in the full Cardiovascular Health Study cohort was skewed toward the right. The WBC count was significantly higher (p < 0.0001) in white men than in white women across the age range, and a significant (p -0.005) increase in WBC count with age was observed in white women but not in white men (table 1) . Blacks did not demonstrate significant age-or sex-associated differences in WBC counts; although there was a tendency toward lower WBC counts with age, the numbers were very small (table 1).
Relation of WBC count to risk factors for ACD
Men and women had similar patterns of significant correlations ( tabolism, and height. Creatinine had a significant positive correlation with WBC counts in men only. In both sexes, WBC count was positively correlated with triglycerides and negatively correlated with high density lipoprotein cholesterol.
Relation of WBC count to smoking
Current smokers (n = 586) had significantly higher mean WBC counts than nonsmokers, regardless of sex (table 3) . These relations were retained for those who had ever smoked (n = 2,148, excluding current smokers) in comparison with those who had never smoked (n = 2,331). The WBC count was higher in both men and women who were passively exposed to tobacco smoke, although this relation did not reach statistical significance in men. Duration of time since cessation of smoking showed no significant effects in the group who had ever smoked (data not shown). The relation of WBC count to risk factors for ACD was further analyzed in the subgroup who had never smoked. Despite the lower absolute levels, the pattern of these risk factor correlations for the never-smoking subgroup was similar to the pattern observed in the entire cohort (table 2) . 
Relation of WBC count to prevalent and subclinical ACD
Mean WBC counts among men and women were lowest in those who were free of disease (6.14 and 5.97 X 10 9 /liter in men and women, respectively; n = 1,502), higher in those with subclinical disease (6.42 and 6.28 X 10 9 /liter, respectively; n = 1,194), and highest in those with prevalent disease (6.58 and 6.42 X 10 9 /liter, respectively; n = 2,453). The p value for each of these comparisons within each sex was less than 0.0001. Mean WBC counts were also higher in men than in women within the disease-free and prevalent disease categories. Higher mean WBC counts were observed for all categories of prevalent disease in both sexes (table 4); associations reached statistical significance for coronary heart disease, stroke/transient ischemic attack, and hypertension, regardless of sex, with only women showing a statistically significantly higher mean WBC count with peripheral vascular disease. Higher WBC counts were observed in both sexes for the following categories of subclinical disease: electrocardiographic abnormalities, ankle:arm blood pressure ratio, maximum carotid stenosis, and abnormal left ventricular wall motion (table 5). Higher mean WBC counts were significantly associated with carotid stenosis in women and abnormal left ventricular ejection fraction in men. Forced expiratory volume (1 second) and forced vital capacity were both significantly and negatively correlated with WBC count in both sexes (table 6).
Most important WBC relations
Sex-specific results of multiple regression analysis are shown in table 7. For both males and females, seven variables were selected for entry into the model at the 1 percent significance level. The variables in the model were identical except for creatinine in men and ever smoking in women. Seventeen percent of the variability in WBC count was associated with these variables. 
DISCUSSION
The frequency distribution of the WBC count in both sexes was skewed toward higher values, as previously described (25) (26) (27) . WBC count was higher in white men than in white women across the observed age range, similarly to the observations in the Atherosclerosis Risk in Communities (ARIC) Study of middle-aged adults (9) but opposite the pattern observed among younger individuals in the CARDIA Study (11) . White women demonstrated an increasing WBC count with age, in contrast to the age-related decrease found among women in previous studies of middle-aged populations (11) .
The associations observed between WBC counts and risk factors for ACD have been previously reported in middle-aged (9, 10, 14) and younger (11) populations. This study extends the observation of these associations to the elderly, where a similar pattern was observed for many of the known cardiovascular risk factors. The inverse relation of WBC count to height is similar to that seen in middle-aged and younger populations (9, 11) . However, in contrast to previous findings (9), measures of body mass and fat distribution, including body weight and hip circumference (with the exception of hip circumference in males who had never smoked), were not associated with increased WBC counts. Body mass is purported to be a risk factor for ACD, and this difference from younger populations may be due to the survivor effect.
The associations between WBC counts and lipid levels are similar to findings from other studies (9, 14) , although we did not observe a relation between WBC count and total cholesterol, which may not be a risk factor in the elderly (16, 17) .
In the ARIC Study, the positive correlation between WBC count and glucose may have been due, at least in part, to catecholamine release related to the stress of the clinic visit (9) . In the Cardiovascular Health Study cohort, higher WBC counts were associated with fasting and 2-hour postprandial glucose and insulin levels, even when nondiabetics were analyzed separately, which supports the ARIC findings.
Fibrinogen, factor VII, and factor VIII were all positively associated with WBC count in the Cardiovascular Health Study cohort. A similar relation was observed in the ARIC Study (9) . The pathophysiologic significance of these observations is unclear at present. However, the role of hemostatic factors in the response-to-injury model (28) hypothesized for the development of ACD is currently under intense investigation, and results suggest that coagulation factors (5, 16, (28) (29) (30) (31) and platelets (32, 33) are associated with ACD. These studies are supported by others that have shown a protective effect of various anticoagulation regimens (34) .
Creatinine was directly related to WBC count in men but not in women, which is perhaps related to the earlier onset of hypertension among men. The longer exposure to hypertension among men leads to more extensive arterionephrosclerosis in comparison with women. Thus, the higher creatinine levels may be reflecting yet another manifestation of the severity of underlying ACD.
Tobacco use has been strongly and positively correlated with WBC count (12) (13) (14) , but it only determines about half of the added risk for ACD observed among individuals with higher WBC counts (15) . Tobacco use, past and current, was highly prevalent in the Cardiovascular Health Study cohort and was significantly associated with higher leukocyte counts. If we assume that higher WBC counts may be caused by smoking, the persistence of higher WBC counts in former smokers is consistent with the notion that the tobacco-induced inflammatory changes may be chronic and may take years to subside. Passive smokers also showed a trend toward higher WBC counts that did not reach statistical significance. We also analyzed the never smokers separately, with similar findings. Thus, it would appear in this cohort that WBC count may be a sensitive indicator of exposure to tobacco use, even when the exposure is remote and indirect.
The prevalent and subclinical disease groups had significantly higher mean leukocyte counts than persons who were free of disease, as seen in previous studies of younger populations (1-5, 9). The associations observed for prevalent disease were supported by the pattern of correlations observed for subclinical disease, with abnormalities documented in the coronary, cerebrovascular, and peripheral vascular systems in the Cardiovascular Health Study population. Furthermore, pulmonary function, measured as both forced expiratory volume and forced vital capacity, was negatively correlated with WBC count, most likely reflecting tobacco use.
Our findings demonstrate strong associations of leukocyte count with many of the known risk factors for ACD, as well as with prevalent and subclinical disease. Our sex-specific multiple regression model (table 7) was constructed from variables selected for entry at the 1 percent significance level. The variables, including forced expiratory volume, fibrinogen, smoking status, triglycerides, fasting glucose, and creatinine (in males), all remained significantly associated with WBC count. These observations are consistent with a number of studies in the literature (1-11) and extend these observations to the elderly.
These associations lead to speculation about the role of leukocytes in atherosclerosis. Two possibly related explanations may be entertained. The observed increased leukocyte counts may be reactive to the inflammatory component of the atherosclerotic process (30, 33, 35) , and/or they may play an active role in the evolution of vascular disease. Atherosclerosis has a chronic inflammatory component, and the relative leukocytosis may simply be a component of the chronic inflammatory response. On the other hand, changes in neutrophil function in association with ischemic heart disease (36, 37) , together with the postulated role for leukocytes, especially monocytes, in the response-toinjury model (37) of ACD pathogenesis, argue that there may be a more direct causal role. Macrophages derived from monocytes are found even in early fatty streaks and are capable of oxidizing lipids, releasing cytotoxic oxygen radicals, releasing growth factors involved in local cellular proliferation, and releasing other cytokines with local and systemic effects. Olivares et al. (10) recently demonstrated that the monocyte count predicted premature coronary disease among middle-aged men. In elderly persons with established ACD, the procoagulant activity of monocytes may be important in the evolution of specific thrombotic events. The perturbed monocyte produces tissue factor (38) , which is considered the primary initiator of most thrombotic events. In fact, it has been postulated that the monocyte may be the major cellular initiator of thrombosis (39) .
In conclusion, this study demonstrates that higher WBC counts in the elderly are associated with prevalent and subclinical ACD, as well as risk factors for ACD. A precise mechanistic understanding of the role of the leukocyte in the evolution of ACD awaits further investigation.
